Last viewed: NVO


Prices are updated after-hours



nyse:NVO Novo Nordisk A/S

NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-1.9% 1m) (29.3% 1y) (0.0% 2d) (-3.8% 3d) (-0.1% 7d) (Infinity% volume)
Earnings Calendar:
http://www.novonordisk.com
Sec Filling | Patents | 43258 employees

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

obesity   diabetes   haemophilia   insulin   diabetic   hormone   growth hormone  

add to watch list email alert is off

Price chart


% (High / Open) change chart




Press-releases


Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
ICLR | News | $219.14 -0.79% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.05% H: 0.96% C: -0.24%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -2.98% H: 0.66% C: -0.87%

trials research technology
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
JNJ | News | $176.94 -2.84% 0.18% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.94% C: 0.26%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 0.0% C: 0.0%
CCXI | $25.08 -3.54% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -4.88% H: 1.04% C: -1.25%
AZN | $65.94 -0.86% 0.21% | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 1.22% C: 0.38%
AZNCF | $127.2501 | twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $84.17 -1.3% 0.17% | twitter stocktwits trandingview |
Health Technology
| | O: 1.86% H: 1.05% C: 0.24%
PFE | News | $50.66 -2.35% 0.4% | twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 1.45% C: 0.78%

disease for therapy growth
Valued to be $3.4 Billion by 2026, Critical Care Therapeutics Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
BMY | $78.7 -1.6% 0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 1.72% C: 0.95%
BAX | $65.25 -2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 4.39% H: 0.97% C: -0.09%
BMRN | $83.23 -2.19% -0.29% | twitter stocktwits trandingview |
Health Technology
| | O: 1.23% H: 0.57% C: -1.48%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 0.0% C: 0.0%
KMDA | $4.54 0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -1.52% H: 0.67% C: -0.88%
ABEO | $0.19 3.77% 1.04% | twitter stocktwits trandingview |
Health Technology
| | O: -5.43% H: 9.2% C: 5.23%

care for therapeutics growth
Innate Pharma to Participate in Upcoming Investor Conference - June 23, 2022
Published: 2022-06-23 (Crawled : 07:00) - biospace.com/
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.85% H: 0.0% C: 0.0%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 1.34% C: 1.31%
IPHA | $2.74 1.83% | twitter stocktwits trandingview |
Health Technology
| | O: -1.85% H: 3.02% C: -1.13%

pharma conference
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Published: 2022-06-22 (Crawled : 11:00) - biospace.com/
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -0.68% H: 0.0% C: 0.0%

partnership nash
Insulin Market to Exceed US$ 30 Bn by 2031; Global Burden of Diabetes and Complications Propelling Adoption of Therapies, Observes TMR Report
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BDX A | $244.53 -2.23% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

report diabetes insulin market
Global Therapeutic Proteins Market Report 2022-2031 Featuring Major Players - Abbott Laboratories; Amgen Inc.; Baxter International Inc.; Eli Lilly and Company; F.Hoffmann-La Roche
Published: 2022-06-20 (Crawled : 15:00) - prnewswire.com
BIIB | $202.53 -5.17% -0.82% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ABT | News | $106.97 -1.93% -0.11% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
AMGN | $243.6 -0.51% 0.47% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
JNJ | News | $176.94 -2.84% 0.18% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BAX | $65.25 -2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

report roche international market
Novo Nordisk A/S – Share repurchase programme
Published: 2022-06-20 (Crawled : 13:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

repurchase
Novo Nordisk A/S – Share repurchase programme
Published: 2022-06-13 (Crawled : 13:20) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -1.92% H: 0.28% C: -1.19%

repurchase
Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency
Published: 2022-06-12 (Crawled : 20:20) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

sogroya treatment children potential living growth hormone
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Last 48 Hours Insiders Buying
ALTG P 3227 | $9.29 -2.52% 0.0% | twitter stocktwits trandingview |
Distribution Services
| 01:40
SKIL P 30000 | $3.61 -6.96% 0.0% | twitter stocktwits trandingview |
Information
| 23:50
CAMP P 20000 | $4.65 -1.27% -0.43% | twitter stocktwits trandingview |
Electronic Technology
| 16:00